# Longevity Vision Holding

Longevity Vision Holding is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** longevity.vision
- **LinkedIn:** https://www.linkedin.com/company/longevityvision

## Regulatory record

- **Reports private funds:** No

## About

Longevity Vision Holding invests in and manages businesses advancing longevity in healthcare and biotechnology. The company's portfolio focuses on extending human lifespan and improving health during aging. Founded in 2019, it is based in New York, New York.

## Sectors

- Digital Health
- AI/ML

## Questions

### What is Longevity Vision Holding's investment thesis?

The firm invests exclusively in the longevity sector — companies that use artificial intelligence and biotechnology to extend human healthspan. Its thesis holds that aging is the primary driver of the most burdensome diseases, and that venture-scale returns are achievable by funding interventions that measure biological age, clear senescent cells, or reprogram cellular function. The firm views aging as a treatable condition rather than an immutable process, a stance that aligns it with a small set of dedicated longevity investors.

### What investment stages does Longevity Vision Holding target?

The firm deploys capital from seed through late-stage venture, with early-stage investments forming the core of its activity. It leads and co-leads rounds, often alongside specialized health-tech and biotech funds. The stage-agnostic approach allows it to support companies from preclinical validation through clinical trials and toward regulatory approval, though follow-on investments depend on milestone achievement.

### How does Longevity Vision Holding source deal flow?

The firm sources deals through academic research networks in aging biology, longevity-focused venture conferences, and co-investor relationships with specialized health-tech funds. Key sourcing hubs include Boston, the San Francisco Bay Area, and Israel, where academic institutions produce a disproportionate share of longevity-related spinouts. The firm's concentrated thesis acts as a filtering mechanism, attracting founders who seek investors fluent in the scientific and regulatory challenges of aging interventions.

## Related profiles

- [Longevity Venture Partners](https://altss.com/profile/longevity-venture-partners)
- [Longford Capital](https://altss.com/profile/longford-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/longevity-vision-holding

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology